Tag: regenerative medicine

Below is a concise tour of what’s genuinely new or newly validated (2024–2025) across longevity science and regeneration—and what it could mean for patients. 1) Senolytics inch toward the clinic Clearing senescent (“zombie”) cells remains a leading strategy to slow multi-tissue decline. New human-relevant data continue to accumulate for the dasatinib+quercetin (D+Q) combo, including cartilage…